Schonfeld Strategic Advisors’s Outset Medical OM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-114,800	Closed	-$1.62M	–	2434
2025 Q3	$1.62M	Sell	114,800 -141,882	-55%	-$2.21M	0.01%	1147
2025 Q2	$4.93M	Buy	256,682 +66,526	+35%	+$1.04M	0.03%	567
2025 Q1	$2.1M	Buy	+190,156	New	+$2.27M	0.01%	946
2024 Q3	–	Sell	-1,027	Closed	-$59.3K	–	2314
2024 Q2	$59.3K	Buy	+1,027	New	+$50.3K	﹤0.01%	1920
2022 Q3	–	Sell	-853	Closed	-$189K	–	3108
2022 Q2	$189K	Buy	853 +526	+161%	+$226K	﹤0.01%	1926
2022 Q1	$223K	Sell	327 -566	-63%	-$341K	﹤0.01%	1879
2021 Q4	$617K	Buy	+893	New	+$660K	0.01%	1160
2021 Q2	–	Sell	-1,027	Closed	-$838K	–	2197
2021 Q1	$838K	Buy	+1,027	New	+$792K	0.01%	961

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Schonfeld Strategic Advisors's OM Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Outset Medical (OM) in Q4 2025, closing a stake of 114,800 shares — an estimated $1.62M sold.

Schonfeld Strategic Advisors first reported a position in OM in Q1 2021 and held it in 8 quarters. The position peaked at $4.93M in Q2 2025. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

Schonfeld Strategic Advisors reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 114,800 Outset Medical shares in Q4 2025, an estimated $1.62M.
Schonfeld Strategic Advisors first reported a position in Outset Medical in Q1 2021 and held it in 8 quarters.
Schonfeld Strategic Advisors's Outset Medical position peaked at $4.93M in Q2 2025.
100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.